FindTrial
Sign In

liothyronine sodium

DRUG6 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), ZonMW, Lucille P. Markey Cancer Center at University of Kentucky, Mayo Clinic, Yonsei University, National Cancer Institute (NCI)

Conditions

Head and Neck CancerHypothyroidism Triiodothyronine Quality of Life Persistant complaintsMultiple SclerosisNon-thyroidal Illness SyndromeProstate CancerThyroid Neoplasm

Phase 1

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
CompletedNCT00004062
Lucille P. Markey Cancer Center at University of KentuckyHead and Neck Cancer
Start: 1999-07-31End: 2006-08-31Updated: 2013-12-19
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy
TerminatedNCT00788307
Mayo ClinicProstate Cancer
Start: 2008-11-03End: 2018-02-07Updated: 2023-04-18
Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
CompletedNCT02760056
Oregon Health and Science UniversityMultiple Sclerosis
Start: 2016-06-06End: 2017-01-10Updated: 2018-11-19

Phase 2

A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
CompletedNCT01182285
National Cancer Institute (NCI)Thyroid Neoplasm
Start: 2010-09-24End: 2016-04-28Updated: 2018-05-16

Phase 3

A national randomized placebo-controlled double-blind multicenter trial of LT4/LT3 combination therapy in patients with autoimmune hypothyroidism: the T3-4-Hypo trial
Not yet recruitingCTIS2024-513883-24-00
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), ZonMWHypothyroidism Triiodothyronine Quality of Life Persistant complaints
Target: 600Updated: 2025-07-11

Unknown Phase

Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery
CompletedNCT01153360
Yonsei UniversityNon-thyroidal Illness Syndrome
Start: 2010-06-30End: 2011-09-30Updated: 2012-07-24

Related Papers

Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes.
2020-02-2034 citations